Our team is composed of experts in nanotechnology with global experience.
Board of Directors
President and CEO of AnGes, Inc., a leading biopharma company specializing in gene therapy. Is also the current CEO of AnGes Euro Ltd. and AnGes USA, Inc.
Former director at Takaro Shuzo Co. and various roles at Sosei K.K. and Mitsubishi Kasei Corporation.
Aharon Schwartz Ph.D.
Former Vice President, Head of Teva Innovative Ventures. Current Director of Protalix Biotherapeutics. He is currently the chairman of the board of BioLineRx Ltd. and a member of the board of Foamix Pharma Ltd.
Aharon received his Ph.D. in organic chemistry from the Weizmann Institute of Science.
CEO and Managing Partner of NGT3VC. Former CEO and director of Beta-O2 Technologies. Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for 11 years.
Zohar led the establishment and investment in more than 50 companies including Prolor Biotech, Mazor Robotics, ReWalk, Corindus, Regentis and many others.
Co-founder of Lilly Ventures and Senior Managing Director at Medimmune Ventures. Former Board Member of Adheron, CGI Therapeutics, G1 Therapeutics, and Remon Medical. Adjunct Professor at Kelley School of Business, Indiana University.
Ron received his M.D. and M.P.H. from the Hebrew University and his MBA from Harvard Business School.
Adv. , LLM
Chief Legal Officer at the Technion R&D Foundation for over 15 years. Specializing in intellectual property laws, leading technology transfer agreements and startups based on Technion technologies and inventions.
Nili serves as a director in the board of directors of many Technion related companies for many years.
Scientific Advisory Board
Inventor and Co-founder
Associate Professor, Faculty of Chemical Engineering at the Technion. Prof. Schroeder is Head of the Targeted Drug Delivery and Personalized Medicine Technologies Laboratory at the Technion.
Co-founder and inventor - ViAqua Therapeutics, Moebius Medical, InPlant, and PEEL Therapeutics.
Yechezkel Barenholz Ph.D.
Professor of Biochemistry at the Hebrew University of Jerusalem. He is on the Editorial Boards of "Chemisty and Physics of Lipids" and the "Journal of Liposome Research". Prof. Barenholz has over 300 publications and over 30 patents
Inventor of the first FDA-approved liposomal medicine and founder of several prominent startups.
Medical Advisory Board
Beatrice Uziely M.D. MPH
Head, Ambulatory Services Unit, Sharett Institute of Oncology, Hadassah. She is a leading mammalogy oncologist and is one of the most well-known experts in the field of treatment of breast cancer.
Received her MD from the Hebrew Univeristy in Jerusalem.
Senior Neurologist, Neuro-Oncologist, and Head of Cancer Computational Biology Lab at Hadassah Medical Center. Expert in computational biology and cancer genomics.
M.D. and Ph.D. in statistical genetics from the Technion.